Pharmacologic Substance: Glucagon-Like Peptide-1 Receptor Agonists

Medical news and research articles

Weight‑loss jabs may create a new kind of yo‑yo dieting

For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after ...

New research reveals rise in obesity rates in the US

Obesity rates among U.S. adults and children rose sharply in recent years, and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published in Circulation.

7 things to know about Medicare's new GLP-1 coverage

For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other ...

Will GLP-1s lead to fewer prescriptions for older adults?

As people age, they often develop chronic conditions, many of which need to be managed with multiple prescription medications. While medications are important for disease management, polypharmacy poses an increased risk for ...

page 1 from 13